Wang, Michael
- UT MD Anderson Cancer Center · Internal Medicine (NIH department code)
From the FY2020 NIH awards this investigator leads as contact PI. The department is the award's.
FY2020 NIH rank #21,517
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2016 through FY2020Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2020 award categories
- Internal Medicine
NIH Funding · FY2020
Linked Award Amount
$174K
Full award amounts, FY2020
Award Records
1
Records listing this PI
Award-Linked Rank
#21,517
By linked amount among FY2020 PIs
Earliest Year Loaded
2016
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2020 award records by amount
NIH award records listing Wang, Michael as a PI. Multi-PI records show the full award amount for context.
- 5R21CA234851-02R21Contact PIFoxM1 as a Novel Therapeutic Target to Overcome Ibrutinib Resistance in Mantle Cell LymphomaUT MD Anderson Cancer Center · Internal Medicine (NIH department code)$174Kaward amount
Award organization
Organizations that administered FY2020 awards listing Wang, Michael as a PI.
FY2020 award administered by UT MD Anderson Cancer Center (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2016First NIH AwardUT MD Anderson Cancer Center
- 2019$500K Cumulative Funding